Cite

HARVARD Citation

    Yao, M. et al. (n.d.). Phase II study of erlotinib and docetaxel with concurrent intensity‐modulated radiotherapy in locally advanced head and neck squamous cell carcinoma. Head & neck. pp. E1770-E1776. [Online]. 
  
Back to record